Digital Biobank

Verisense Health is building a Digital Biobank to provide the data to identify and validate Digital Biomarkers. The Digital Biobank is a repository of raw digital sensor data with associated patient reported outcomes and tokens to enable access to real world data, including medical records, claims data, pharmacy data, etc. on an anonymous basis.  The Digital Biobank is being seeded with data collected by Verisense Health, both from internally sponsored studies and from external sponsors who are leveraging Verisense Health’s highly efficient infrastructure, the Digital Health Panel

The Digital Health Panel combines decentralized trial approaches with existing infrastructure and RWD.

Participant Management Partner

  • 22 Locations

  • 400k existing panel members

  • 300+ diseases

  • Hundres of projects per year

Verisense Health sits at the center of this infrastructure with it’s custom built data collection and study management platform integrating data from a variety of partners:

Customers/ Sponsors of Research

  • Commission new research

  • Provide existing datasets

Real-World Data (RWD) Partners

  • Generate tokens

  • Provide pseudonymized participant RWD, as needed

3rd Party Device Integration

Verisense Health will work with any digital health technology provider that is committed to providing raw data. The use of raw data makes the Digital Biobank device agnostic in that any device using the same type of sensors (e.g., accelerometers) can utilize analysis algorithms developed with these data.  In addition, Verisense Health will work with any device manufacturer to incorporate their data into the Digital Biobank.

Examples of Technologies that might be added to Study:

  • Motion and/or Biophysical sensors

  • BT Weight Sclaes

  • ECG Patches